• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation.
CONCLUSION: We suggest that the age influenced TTR through greater drug adherence. Strategies for increasing drug adherence might improve quality of warfarin anticoagulation. PMID: 27486984 [PubMed - as supplied by publisher]
Source: Oncotarget - August 5, 2016 Category: Cancer & Oncology Tags: Oncotarget Source Type: research

New Alternative Anticoagulants in Atrial Fibrillation: The Move Beyond Warfarin.
Abstract Given the increasing prevalence of atrial fibrillation, the need for safe and effective stroke prophylaxis will continue to rise. Warfarin has been around for many years and has proven efficacy in preventing stroke, but it has major limitations due to its variable dosing, food and drug interactions, and requirement for regular monitoring. Newer agents which include dabigatran, rivaroxaban, and apixaban have recently or will soon be available and may provide an improved efficacy in stroke prevention, an improved safety profile, and improved user-friendliness. Dabigatran was the first of the agents to be wi...
Source: Reviews on Recent Clinical Trials - July 5, 2013 Category: Cancer & Oncology Authors: Bhimani AA, Hong M Tags: Rev Recent Clin Trials Source Type: research

Managing the Risks of Cardiac Therapy in Cancer Patients
The purpose of this review was to highlight the more commonly used cardiac medications that should be closely monitored or possibly discontinued during cancer therapy. Often, older cancer patients are taking multiple pharmacotherapy agents for the treatment or prevention of cardiac disease when they face decisions about cancer treatment. Concurrent administration of drugs can result either in increased toxicity or decreased efficacy of either therapy. The benefits of the cardiac medications must be weighed against the effects of cancer therapy, and the role of drug metabolism also must be considered. For example, the benef...
Source: Seminars in Oncology - April 1, 2013 Category: Cancer & Oncology Authors: Carol L. Chen, Rekha Parameswaran Tags: Marc L. Schwartz, ME, Guest Editor Source Type: research

The Prevalence, Impact and Economic Implications of Atrial Fibrillation in Stroke: What Progress Has Been Made?
Neuroepidemiology 2013;40:227–239 (DOI:10.1159/000343667)
Source: Karger Publishers - January 23, 2013 Category: Cancer & Oncology Source Type: research

FDA approves Eliquis to prevent stroke, blood clots in atrial fibrillation
Source: HemOncToday.com - December 31, 2012 Category: Cancer & Oncology Source Type: news

Pages: 1  2  3  4  5  6  7